Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Efficacy of folic acid supplementation in stroke prevention: a meta-analysis.

Wang X, Qin X, Demirtas H, Li J, Mao G, Huo Y, Sun N, Liu L, Xu X.

Lancet. 2007 Jun 2;369(9576):1876-82. Review.

PMID:
17544768
2.

Efficacy of folic acid supplementation in cardiovascular disease prevention: an updated meta-analysis of randomized controlled trials.

Yang HT, Lee M, Hong KS, Ovbiagele B, Saver JL.

Eur J Intern Med. 2012 Dec;23(8):745-54. doi: 10.1016/j.ejim.2012.07.004. Epub 2012 Aug 11.

PMID:
22884409
3.

Efficacy of homocysteine-lowering therapy with folic Acid in stroke prevention: a meta-analysis.

Lee M, Hong KS, Chang SC, Saver JL.

Stroke. 2010 Jun;41(6):1205-12. doi: 10.1161/STROKEAHA.109.573410. Epub 2010 Apr 22.

4.

Effect of folic acid supplementation on the progression of carotid intima-media thickness: a meta-analysis of randomized controlled trials.

Qin X, Xu M, Zhang Y, Li J, Xu X, Wang X, Xu X, Huo Y.

Atherosclerosis. 2012 Jun;222(2):307-13. doi: 10.1016/j.atherosclerosis.2011.12.007. Epub 2011 Dec 9. Review.

PMID:
22209480
5.

[Meta-analysis on effect of combined supplementation of folic acid, vitamin B12 and B6 on risk of cardio-cerebrovascular diseases in randomized control trials].

Lan X, Dang SN, Zhao YL, Yan H, Yan H.

Zhonghua Liu Xing Bing Xue Za Zhi. 2016 Jul;37(7):1028-34. doi: 10.3760/cma.j.issn.0254-6450.2016.07.024. Chinese.

PMID:
27453118
6.

Homocysteine-lowering therapy with folic acid is effective in cardiovascular disease prevention in patients with kidney disease: a meta-analysis of randomized controlled trials.

Qin X, Huo Y, Xie D, Hou F, Xu X, Wang X.

Clin Nutr. 2013 Oct;32(5):722-7. doi: 10.1016/j.clnu.2012.12.009. Epub 2012 Dec 28.

PMID:
23313356
7.

The effect of folate fortification on folic acid-based homocysteine-lowering intervention and stroke risk: a meta-analysis.

Zeng R, Xu CH, Xu YN, Wang YL, Wang M.

Public Health Nutr. 2015 Jun;18(8):1514-21. doi: 10.1017/S1368980014002134. Epub 2014 Oct 17. Review.

PMID:
25323814
8.

Efficacy of folic acid supplementation in stroke prevention: new insight from a meta-analysis.

Huo Y, Qin X, Wang J, Sun N, Zeng Q, Xu X, Liu L, Xu X, Wang X.

Int J Clin Pract. 2012 Jun;66(6):544-51. doi: 10.1111/j.1742-1241.2012.02929.x. Review.

PMID:
22607506
9.

[Vitamin treatments that lower homocysteine concentration: can they decrease cerebrovascular disease in primary prevention?].

Méndez-González J, Rodríguez-Millán E, Julve J, Blanco-Vaca F.

Rev Neurol. 2010 Feb 16-28;50(4):235-44. Review. Spanish.

10.

Meta-analysis of folic acid efficacy trials in stroke prevention: Insight into effect modifiers.

Zhao M, Wu G, Li Y, Wang X, Hou FF, Xu X, Qin X, Cai Y.

Neurology. 2017 May 9;88(19):1830-1838. doi: 10.1212/WNL.0000000000003909. Epub 2017 Apr 12.

PMID:
28404799
11.

Homocysteine-lowering trials for prevention of cardiovascular events: a review of the design and power of the large randomized trials.

B-Vitamin Treatment Trialists' Collaboration.

Am Heart J. 2006 Feb;151(2):282-7. Review.

PMID:
16442889
12.

Folic acid therapy and cardiovascular disease in ESRD or advanced chronic kidney disease: a meta-analysis.

Qin X, Huo Y, Langman CB, Hou F, Chen Y, Matossian D, Xu X, Wang X.

Clin J Am Soc Nephrol. 2011 Mar;6(3):482-8. doi: 10.2215/CJN.05310610. Epub 2010 Nov 18.

13.

Meta-analysis of folic acid supplementation trials on risk of cardiovascular disease and risk interaction with baseline homocysteine levels.

Miller ER 3rd, Juraschek S, Pastor-Barriuso R, Bazzano LA, Appel LJ, Guallar E.

Am J Cardiol. 2010 Aug 15;106(4):517-27. doi: 10.1016/j.amjcard.2010.03.064.

PMID:
20691310
14.

Effect of B-vitamin supplementation on stroke: a meta-analysis of randomized controlled trials.

Zhang C, Chi FL, Xie TH, Zhou YH.

PLoS One. 2013 Nov 25;8(11):e81577. doi: 10.1371/journal.pone.0081577. eCollection 2013.

15.

Lowering homocysteine for stroke prevention.

Carlsson CM.

Lancet. 2007 Jun 2;369(9576):1841-2. No abstract available.

PMID:
17544750
17.

Homocysteine-lowering trials for prevention of heart disease and stroke.

Clarke R.

Semin Vasc Med. 2005 May;5(2):215-22. Review.

PMID:
16047274
18.
19.

Homocysteine-lowering therapy does not lead to reduction in cardiovascular outcomes in chronic kidney disease patients: a meta-analysis of randomised, controlled trials.

Pan Y, Guo LL, Cai LL, Zhu XJ, Shu JL, Liu XL, Jin HM.

Br J Nutr. 2012 Aug;108(3):400-7. doi: 10.1017/S0007114511007033. Epub 2012 Jan 16. Review.

PMID:
22244447
20.

The effect of folic acid based homocysteine lowering on cardiovascular events in people with kidney disease: systematic review and meta-analysis.

Jardine MJ, Kang A, Zoungas S, Navaneethan SD, Ninomiya T, Nigwekar SU, Gallagher MP, Cass A, Strippoli G, Perkovic V.

BMJ. 2012 Jun 13;344:e3533. doi: 10.1136/bmj.e3533. Review.

Supplemental Content

Support Center